Predicting Cancer Biomarkers from Gene Expression Data
Author Information
Author(s): Gormley Michael, Dampier William, Ertel Adam, Karacali Bilge, Tozeren Aydin
Primary Institution: School of Biomedical Engineering, Drexel University, Philadelphia, PA, USA
Hypothesis
Can gene expression profiles accurately predict molecular phenotypes and relapse in cancer?
Conclusion
Many gene sets can accurately predict molecular phenotypes, but predicting relapse from microarray data is challenging.
Supporting Evidence
- The study found that supervised feature selection led to more accurate classifications than random selection.
- Expression profiles correlated with molecular phenotypes were identified across multiple datasets.
- Prediction error for relapse-free status was consistently high across different cancer types.
Takeaway
Scientists looked at gene data to find patterns that can help predict cancer types and outcomes, but it's hard to guess if someone will relapse just from this data.
Methodology
The study used supervised univariate feature selection algorithms on multiple microarray datasets to create expression profiles.
Potential Biases
Potential overfitting due to the use of leave-one-out cross-validation and variability in sample populations.
Limitations
The study faced challenges in predicting relapse due to high prediction errors and variability in gene expression across datasets.
Participant Demographics
Included patients with breast cancer, lymphoma, and renal cancer from multiple datasets.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website